Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: A prospective randomized study

Epilepsy and Behavior

Volumn 14, Issue 4, 2009, Pages 610-616

  Kwan, Patrick ^a   Yip, Fung Ping ^a,b   Hui, Andrew C F ^a   Leung, Howan ^a   Ng, Ping Wing ^c   Hui, Kwok Fai ^c   Chan, Iris H S ^b   Chan, Michael H M ^b   Lam, Christopher W K ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

Author keywords

Antiepileptic drug; Dehydroepiandrosterone; Follicle stimulating hormone; Glucose; Insulin; Lamotrigine; Lipids; Luteinizing hormone; Testosterone; Valproate

Indexed keywords

FOLLITROPIN; INSULIN; LAMOTRIGINE; LUTEINIZING HORMONE; PRASTERONE SULFATE; TESTOSTERONE; VALPROIC ACID;

ADULT; ARTICLE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG DOSE TITRATION; DRUG ERUPTION; ENDOCRINE FUNCTION; EPILEPSY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; METABOLIC PARAMETERS; METABOLISM; MONOTHERAPY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; SIDE EFFECT; TREATMENT DURATION; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHINA; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE SYSTEM; EPILEPSY; FEMALE; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; INSULIN; LUTEINIZING HORMONE; MALE; METABOLOME; MIDDLE AGED; PROSPECTIVE STUDIES; TESTOSTERONE; TIME FACTORS; TRIAZINES; VALPROIC ACID; YOUNG ADULT;

EID: 63749090255     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.01.010     Document Type: Article

References (31)

1. Isojarvi J.I., Laatikainen T.J., Knip M., Pakarinen A.J., Juntunen K.T.S., and Myllyla V.V. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 39 (1996) 579-584
2. Isojarvi J.I., Rattya J., Myllyla V.V., et al. Valproate, lamotrigine and insulin-mediated risks in women with epilepsy. Ann Neurol 43 (1998) 446-451
3. Pylvanen V., Knip M., Pakarinen A., Kotila M., Turkka J., and Isojarvi J.I. Serum insulin and leptin levels in valproate-associated obesity. Epilepsia 43 (2002) 514-517
4. Isojarvi J.I., Laatikainen T.J., Pakarinen A.J., Juntunen K.T., and Myllyla V.V. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 329 (1993) 1383-1388
5. Isojarvi J.I., Tauboll E., Pakarinen A.J., et al. Altered ovarian function and cardiovascular risk factors in valproate treated women. Am J Med 111 (2001) 290-296
6. Isojarvi J.I., Tauboll E., and Herzog A.G. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drugs 19 (2005) 207-223
7. Pylvanen V., Knip M., Pakarinen A.J., et al. Fasting serum insulin and lipid levels in men with epilepsy. Neurology 60 (2003) 571-574
8. Rattya J., Turkka J., Pakarinen A.J., et al. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Neurology 56 (2001) 31-36
9. Isojarvi J.I., Pakarinen A.J., Ylipalosaari P.J., and Myllyla V.V. Serum hormones in male epileptic patients receiving anticonvulsant medication. Arch Neurol 47 (1990) 670-676
10. Geisler J., Engelsen B.A., Berntsen H., Geisler S., and Lonning P.E. Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients. J Endocrinol 153 (1997) 307-312
11. Kwan P., and Brodie M.J. Effectiveness of first antiepileptic drug. Epilepsia 42 (2001) 1255-1260
12. Devinsky O., Vuong A., Hammer A., and Barrett P.S. Stable weight during lamotrigine therapy: a review of 32 studies. Neurology 54 (2000) 973-975
13. Biton V., Mirza W., Montouris G., Vuong A., Hammer A.E., and Barrett P.S. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 56 (2001) 172-177
14. Morrell M.J., Isojarvi J., Taylor A.E., et al. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res 54 (2003) 189-199
15. Rattya J., Pakarinen A.J., Knip M., Repo-Outakoski M., Myllyla V.V., and Isojarvi J.I. Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 57 (2001) 440-444
16. Stephen L.J., Sills G.J., Leach J.P., et al. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy. Epilepsy Res 75 (2007) 122-129
17. Morrell M.J., Hayes F.J., Sluss P.M., et al. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. Ann Neurol 64 (2008) 200-211
18. Yan L.X., and Jing D. Clinical features of polycystic ovarian syndrome (PCOS) in China. Fertil Infertil 84 Suppl. 1 (2005) S167-S168
19. Stephen L.J., Kwan P., Shapiro D., Dominiczak M., and Brodie M.J. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia 42 (2001) 1002-1006
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and B-cell function from fasting PG and insulin concentrations in man. Diabetologia 28 (1985) 412-419
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
22. Pylvanen V., Pakarinen A., Knip M., and Isojarvi J. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. Epilepsy Behav 8 (2006) 643-648
23. Ko G.T.C., Cockram C.S., Chow C.-C., et al. High prevalence of metabolic syndrome in Hong Kong Chinese: comparison of three diagnostic criteria. Diabetes Res Clin Pract 69 (2005) 160-168
24. Pylvanen V., Pakarinen A., Knip M., and Isojarvi J. Characterization of insulin secretion in valproate-treated patients with epilepsy. Epilepsia 47 (2006) 1460-1464
25. Roste L.S., Tauboll E., Morkrid L., et al. Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy. Eur J Neurol 12 (2005) 118-124
26. Walker W.H., and Cheng J. FSH and testosterone signaling in Sertoli cells. Reproduction 130 (2005) 15-28
27. Foresta C., Selice R., Garolla A., and Ferlin A. Follicle-stimulating hormone treatment of male infertility. Curr Opin Urol 18 (2008) 602-607
28. 4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17β-estradiol and pregnanediol levels in urine of normal cycling women. J Cardiovasc Pharmacol 36 Suppl. 1 (2000) S421-S427
29. Guay A.T. Screening for androgen deficiency in women: methodological and interpretive issues. Fertil Steril 77 Suppl. 4 (2002) S83-S88
30. Battaglia C., Nappi R.E., Mancini F., et al. Menstrual cycle-related morphometric and vascular modifications of the clitoris. J Sex Med 5 (2008) 2853-2861
31. Salonia A., Pontillo M., Nappi R.E., et al. Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function. J Sex Med 5 (2008) 854-863